SYBX - Synlogic Inc
Previous close
1.49
0 0%
Share volume: 632
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.49
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-29 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-19 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 143.545 M | 128.237 M | 110.865 M | 93.443 M | 79.284 M | 66.254 M | 75.550 M | 36.057 M | |
| Current Assets | 111.097 M | 97.458 M | 79.782 M | 62.359 M | 49.557 M | 37.780 M | 49.907 M | 34.946 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.306 M | 4.302 M | 2.153 M | 4.991 M | 3.296 M | 4.365 M | 2.161 M | 2.429 M | |
| Short Term Investments | 4.306 M | 4.302 M | 2.153 M | 4.991 M | 3.296 M | 4.365 M | 2.161 M | 2.429 M | |
| Total Receivables | 0.000 | 1.500 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 106.791 M | 91.656 M | 77.629 M | 57.368 M | 46.261 M | 33.415 M | 47.746 M | 32.311 M | |
| Total Non-current Assets | 32.448 M | 30.779 M | 31.083 M | 31.084 M | 29.727 M | 28.474 M | 25.643 M | 1.111 M | |
| Property Plant Equipment | 8.464 M | 7.901 M | 7.323 M | 6.885 M | 6.398 M | 5.949 M | 5.603 M | 0.000 | |
| Other Assets | 22.887 M | 21.781 M | 22.663 M | 23.102 M | 22.232 M | 21.428 M | 18.943 M | 14.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 143.545 M | 128.237 M | 110.865 M | 93.443 M | 79.284 M | 66.254 M | 75.550 M | 36.057 M | |
| Total liabilities | 26.195 M | 27.809 M | 28.255 M | 24.731 M | 24.510 M | 22.850 M | 32.895 M | 22.732 M | |
| Total current liabilities | 8.906 M | 11.602 M | 12.122 M | 9.737 M | 9.632 M | 9.144 M | 20.404 M | 10.940 M | |
| Accounts Payable | 1.502 M | 1.718 M | 1.785 M | 2.316 M | 1.082 M | 708.000 K | 1.457 M | 719.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 4.006 M | 4.143 M | 4.165 M | 4.308 M | 4.350 M | 4.493 M | 4.784 M | 2.672 M | |
| Long term debt | 17.289 M | 16.207 M | 16.133 M | 14.994 M | 14.878 M | 13.706 M | 12.491 M | 11.792 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 117.350 M | 100.428 M | 82.610 M | 68.712 M | 54.774 M | 43.404 M | 42.655 M | 13.325 M | |
| Common stock | 4.807 M | 4.807 M | 4.715 M | 4.605 M | 4.681 M | 4.700 M | 12.023 M | 12.131 M | |
| Retained earnings | -322.411 M | -340.323 M | -357.019 M | -372.641 M | -387.689 M | -399.767 M | -414.301 M | -445.865 M |